We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
Already have an account? Sign in.

 Remember Me | Forgot Your Password?

FMC Acquires Omega-3 Concentrates Manufacturer Epax

July 24, 2013: 12:00 AM EST
FMC Corp. announced its acquisition of all the shares of Epax Nutra Holdings III AS and Epax UK Holdings III AS, manufacturer of high-purity, premium-grade Omega-3 fatty acid concentrates. Estimated to be worth $345 million, the purchase deal reinforces FMC’s business operations in the fast growing nutraceutical market. Epax uses proprietary purification and concentration production processes in manufacturing Omega-3 fatty acids that are used mainly in the nutraceutical, food, and active pharmaceutical ingredient intermediate markets. As part of the deal, FMC also takes possession of Epax’s world-scale production facilities in Alesund, Norway, and Seal Sands in the UK.
"FMC Corporation Acquires Leading High-Purity Omega-3 Concentrates Producer Epax", FMC Corporation, July 24, 2013, © FMC Corporation
North America
United States of America
United Kingdom
Companies, Organizations
Deals, M&A, JVs, Licensing
Market News
Press Release
Developed by Yuri Ingultsov Software Lab.